The data was obtained from Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo) and included studies that determined the expression profiles of MCF7 cells, which are ER-positive breast cancer cells, that were mock-treated or treated with estradiol (E2; the primary type of estrogen). Here, ESR1 is linked to breast carcinoma.